Table 2.
Univariate Analysis of Clinical Factors on 101 Patients with OS
| Variables | HR | (95% CI) | p |
|---|---|---|---|
| Gender | |||
| Male | 1.019 | (0.344–3.021) | 0.972 |
| Female | 1 | ||
| Age (years) | |||
| ≤65 | 1 | (0.352–1.896) | 0.638 |
| >65 | 0.817 | ||
| Recurrence | |||
| Yes | 1.116 | (0.414–3.009) | 0.829 |
| No | 1 | ||
| Number of tumors | |||
| Single | 1 | (0.169–1.473) | 0.208 |
| Multiple | 0.498 | ||
| Tumor size (cm) | |||
| ≤5 | 3.342 | (1.442–7.746) | 0.005 |
| >5 | 1 | ||
| Operation mode | |||
| Transurethral resection | 1.693 | (0.704–4.075) | 0.240 |
| Radical cystectomy | 1 | ||
| Adjuvant chemotherapy | |||
| Yes | 1.105 | (0.475–2.573) | 0.817 |
| No | 1 | ||
| Bladder triangle involvement | |||
| Yes | 2.105 | (0.491–9.023) | 0.316 |
| No | 1 | ||
| External invasion | |||
| Yes | 1 | (0.229–2.027) | 0.490 |
| No | 0.681 | ||
| Vascular tumor thrombus | |||
| Yes | 1 | (0.135–0.885) | 0.027 |
| No | 0.345 | ||
| T stage | |||
| T1 | 50.404 | (5.122–496.040) | 0.001 |
| T2+T3+T4 | 1 | ||
| Grade | |||
| G1+G2 | 11.915 | (3.34–42.504) | 0.000 |
| G3 | 1 | ||
| Lymph node metastasis | |||
| Yes | 1.054 | (0.426–2.608) | 0.909 |
| No | 1 | ||
| Other site metastasis | |||
| Yes | 1 | (0.145–1.283) | 0.131 |
| No | 0.431 | ||
| Expression of KRT17 | |||
| Low expression | 1 | (0.034–0.320) | 0.000 |
| High expression | 0.105 |